OJEMD  Vol.4 No.3 , March 2014
Short Report: Association of IL-15 with Peripheral and Hepatic Insulin Sensitivity in Healthy Middle-Aged Men
Abstract: Rodent study suggests that interleukin (IL)-15 administration enhances insulin sensitivity. Although it is well known that circulating levels of typical inflammatory markers (C-reactive protein [CRP] and IL-6) are positively associated with homeostasis model assessment-insulin resistance (HOMA-IR), there are no studies investigating the associations of other inflammatory markers including IL-15 with peripheral/hepatic insulin sensitivity in humans. The current study aimed to examine the relationship between the levels of adiopokines or inflammatory cytokines and insulin sensitivity in 8 healthy middle-aged men. Circulating levels of 10 insulin sensitizing adipokines or inflammatory cytokines (total adiponectin [APN], high molecular weight adiponectin [HMW-APN], IL-4, IL-5, IL-6, IL-8, IL-15, interferon [IFN]-γ, tumor necrosis factor [TNF]-α, and TNF-β) were measured. A stable-labeled frequently sampled intravenous glucose tolerance test was performed to assess peripheral () and hepatic () insulin sensitivity estimated by 2-compartment minimal model. The levels of 3 inflammatory cytokines (IL-4, IL-6, and IL-15) were significantly and inversely correlated with either and . The association between IL-15 and either or was significant even after adjusting for age and percent body fat (p < 0.01). The current study showed a possible inverse association between serum IL-15 level and peripheral/hepatic insulin sensitivity in healthy middle-aged males, independent of percent body fat; this association in humans warrants further study.
Cite this paper: Nishida, Y. , Tokuyama, K. , Nagasaka, S. , Kiyonaga, A. , Higaki, Y. , Hara, M. , Tanaka, K. and Tanaka, H. (2014) Short Report: Association of IL-15 with Peripheral and Hepatic Insulin Sensitivity in Healthy Middle-Aged Men. Open Journal of Endocrine and Metabolic Diseases, 4, 59-67. doi: 10.4236/ojemd.2014.43007.

[1]   Pickup, J.C. (2004) Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes. Diabetes Care, 27, 813-823.

[2]   Hotamisligil, G.S. (2006) Inflammation and Metabolic Disorders. Nature, 444, 860-867.

[3]   Krogh-Madsen, R., Plomgaard, P., Moller, K., Mittendorfer, B. and Pedersen, B.K. (2006) Influence of TNF-α and IL-6 Infusions on Insulin Sensitivity and Expression of IL-18 in Humans. American Journal of Physiology: Endocrinology and Metabolism, 291, E108-114.

[4]   Saghizadeh, M., Ong, J.M., Garvey, W.T., Henry, R.R. and Kern, P.A. (1996) The Expression of TNFα by Human Muscle. Relationship to Insulin Resistance. Journal of Clinical Investigation, 97, 1111-1116.

[5]   Schmidt, M.I., Duncan, B.B., Sharrett, A.R., Lindberg, G., Savage, P.J., Offenbacher, S., Azambuja, M.I., Tracy, R.P. and Heiss, G. (1999) Markers of Inflammation and Prediction of Diabetes Mellitus in Adults (Atherosclerosis Risk in Communities Study): A Cohort Study. Lancet, 353, 1649-1652.

[6]   Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E. and Ridker, P.M. (2001) C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. JAMA, 286, 327-334.

[7]   Marques-Vidal, P., Bastardot, F., von Kanel, R., Paccaud, F., Preisig, M., Waeber, G. and Vollenweider, P. (2013) Association between Circulating Cytokine Levels, Diabetes and Insulin Resistance in a Population-Based Sample (CoLaus study). Clinical Endocrinology, 78, 232-241.

[8]   Abbatecola, A.M., Ferrucci, L., Grella, R., Bandinelli, S., Bonafe, M., Barbieri, M., Corsi, A.M., Lauretani, F., Franceschi, C. and Paolisso, G. (2004) Diverse Effect of Inflammatory Markers on Insulin Resistance and Insulin-Resistance Syndrome in the Elderly. Journal of the American Geriatrics Society, 52, 399-404.

[9]   Lee, Y.W., Kuhn, H., Hennig, B., Neish, A.S. and Toborek, M. (2001) IL-4-Induced Oxidative Stress Upregulates VCAM-1 Gene Expression in Human Endothelial Cells. Journal of Molecular and Cellular Cardiology, 33, 83-94.

[10]   Gerszten, R.E., Garcia-Zepeda, E.A., Lim, Y.C., Yoshida, M., Ding, H.A., Gimbrone Jr., M.A., Luster, A.D., Luscinskas, F.W. and Rosenzweig, A. (1999) MCP-1 and IL-8 Trigger Firm Adhesion of Monocytes to Vascular Endothelium under Flow Conditions. Nature, 398, 718-723.

[11]   Houtkamp, M.A., van Der Wal, A.C., de Boer, O.J., van Der Loos, C.M., de Boer, P.A., Moorman, A.F. and Becker, A.E. (2001) Interleukin-15 Expression in Atherosclerotic Plaques: An Alternative Pathway for T-Cell Activation in Atherosclerosis? Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1208-1213.

[12]   Kaibe, M., Ohishi, M., Ito, N., Yuan, M., Takagi, T., Terai, M., Tatara, Y., Komai, N., Rakugi, H. and Ogihara, T. (2005) Serum Interleukin-15 Concentration in Patients with Essential Hypertension. American Journal of Hypertension, 18, 1019-1025.

[13]   Barra, N.G., Chew, M.V., Holloway, A.C. and Ashkar, A.A. (2012) Interleukin-15 Treatment Improves Glucose Homeostasis and Insulin Sensitivity in Obese Mice. Diabetes, Obesity and Metabolism, 14, 190-193.

[14]   Nagasaka, S., Tokuyama, K., Kusaka, I., Hayashi, H., Rokkaku, K., Nakamura, T., Kawakami, A., Higashiyama, M., Ishikawa, S. and Saito, T. (1999) Endogenous Glucose Production and Glucose Effectiveness in Type 2 Diabetic Subjects Derived from Stable-Labeled Minimal Model Approach. Diabetes, 48, 1054-1060.

[15]   Nishida, Y., Tokuyama, K., Nagasaka, S., Higaki, Y., Fujimi, K., Kiyonaga, A., Shindo, M., Kusaka, I., Nakamura, T., Ishikawa, S.E., Saito, T., Nakamura, O., Sato, Y. and Tanaka, H. (2002) SG, SI, and EGP of Exercise-Trained Middle-Aged Men Estimated by a Two-Compartment Labeled Minimal Model. American Journal of Physiology: Endocrinology and Metabolism, 283, E809-E816.

[16]   Nishida, Y., Tokuyama, K., Nagasaka, S., Higaki, Y., Shirai, Y., Kiyonaga, A., Shindo, M., Kusaka, I., Nakamura, T., Ishibashi, S. and Tanaka, H. (2004) Effect of Moderate Exercise Training on Peripheral Glucose Effectiveness, Insulin Sensitivity, and Endogenous Glucose Production in Healthy Humans Estimated by a Two-Compartment-Labeled Minimal Model. Diabetes, 53, 315-320.

[17]   Tokuyama, K., Nagasaka, S., Mori, S., Takahashi, N., Kusaka, I., Kiyonaga, A., Tanaka, H., Shindo, M. and Ishibashi, S. (2009) Hepatic Insulin Sensitivity Assessed by Integrated Model of Hepatic and Peripheral Glucose Regulation. Diabetes Technology & Therapeutics, 11, 487-492.

[18]   Goldman, R.F. and Buskirk, E.R. (1961) A Method for Underwater Weighing and the Determination of Body Density. In: Brozekand, J. and Hershel, A., Eds., Techniques for Measuring Body Composition, National Research Council, Washington DC, 78-89.

[19]   Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. and Turner, R.C. (1985) Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man. Diabetologia, 28, 412-419.

[20]   Christiansen, T., Paulsen, S.K., Bruun, J.M., Pedersen, S.B. and Richelsen, B. (2010) Exercise Training Versus Diet-Induced Weight-Loss on Metabolic Risk Factors and Inflammatory Markers in Obese Subjects: A 12-Week Randomized Intervention Study. American Journal of Physiology: Endocrinology and Metabolism, 298, E824-E831.

[21]   Beavers, K.M., Hsu, F.C., Isom, S., Kritchevsky, S.B., Church, T., Goodpaster, B., Pahor, M. and Nicklas, B.J. (2010) Long-Term Physical Activity and Inflammatory Biomarkers in Older Adults. Medicine & Science in Sports & Exercise, 42, 2189-2196.

[22]   Nishida, Y., Higaki, Y., Tokuyama, K., Fujimi, K., Kiyonaga, A., Shindo, M., Sato, Y. and Tanaka, H. (2001) Effect of Mild Exercise Training on Glucose Effectiveness in Healthy Men. Diabetes Care, 24, 1008-1013.

[23]   McDonald, P.P., Russo, M.P., Ferrini, S. and Cassatella, M.A. (1998) Interleukin-15 (IL-15) Induces NF-κB Activation and IL-8 Production in Human Neutrophils. Blood, 92, 4828-4835.

[24]   Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J. and Shoelson, S.E. (2005) Local and Systemic Insulin Resistance Resulting from Hepatic Activation of IKK-β and NF-κB. Nature Medicine, 11, 183-190.

[25]   Ajuwon, K.M. and Spurlock, M.E. (2004) Direct Regulation of Lipolysis by Interleukin-15 in Primary Pig Adipocytes. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 287, R608-R611.

[26]   Hawkins, M., Barzilai, N., Liu, R., Hu, M., Chen, W. and Rossetti, L. (1997) Role of the Glucosamine Pathway in Fat-Induced Insulin Resistance. Journal of Clinical Investigation, 99, 2173-2182.

[27]   Alleva, D.G., Kaser, S.B., Monroy, M.A., Fenton, M.J. and Beller, D.I. (1997) IL-15 Functions as a Potent Autocrine Regulator of Macrophage Proinflammatory Cytokine Production: Evidence for Differential Receptor Subunit Utilization Associated with Stimulation or Inhibition. Journal of Immunology, 159, 2941-2951.

[28]   Senn, J.J., Klover, P.J., Nowak, I.A. and Mooney, R.A. (2002) Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes. Diabetes, 51, 3391-3399.

[29]   Jonuleit, H., Wiedemann, K., Muller, G., Degwert, J., Hoppe, U., Knop, J. and Enk, A.H. (1997) Induction of IL-15 Messenger RNA and Protein in Human Blood-Derived Dendritic Cells: A Role for IL-15 in Attraction of T Cells. Journal of Immunology, 158, 2610-2615.

[30]   Carbo, N., Lopez-Soriano, J., Costelli, P., Alvarez, B., Busquets, S., Baccino, F.M., Quinn, L.S., Lopez-Soriano, F.J. and Argiles, J.M. (2001) Interleukin-15 Mediates Reciprocal Regulation of Adipose and Muscle Mass: A Potential Role in Body Weight Control. Biochimica et Biophysica Acta, 1526, 17-24.

[31]   Nielsen, A.R., Hojman, P., Erikstrup, C., Fischer, C.P., Plomgaard, P., Mounier, R., Mortensen, O.H., Broholm, C., Taudorf, S., Krogh-Madsen, R., Lindegaard, B., Petersen, A.M., Gehl, J. and Pedersen, B.K. (2008) Association between Interleukin-15 and Obesity: Interleukin-15 as a Potential Regulator of Fat Mass. The Journal of Clinical Endocrinology & Metabolism, 93, 4486-4493.

[32]   Fernandez-Real, J.M., Vayreda, M., Richart, C., Gutierrez, C., Broch, M., Vendrell, J. and Ricart, W. (2001) Circulating Interleukin 6 Levels, Blood Pressure, and Insulin Sensitivity in Apparently Healthy Men and Women. The Journal of Clinical Endocrinology & Metabolism, 86, 1154-1159.